Suppr超能文献

动脉粥样硬化中细胞代谢的失调:介质和治疗机会。

Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities.

机构信息

Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

La Jolla Institute for Immunology, La Jolla, CA, USA.

出版信息

Nat Metab. 2024 Apr;6(4):617-638. doi: 10.1038/s42255-024-01015-w. Epub 2024 Mar 26.

Abstract

Accumulating evidence over the past decades has revealed an intricate relationship between dysregulation of cellular metabolism and the progression of atherosclerotic cardiovascular disease. However, an integrated understanding of dysregulated cellular metabolism in atherosclerotic cardiovascular disease and its potential value as a therapeutic target is missing. In this Review, we (1) summarize recent advances concerning the role of metabolic dysregulation during atherosclerosis progression in lesional cells, including endothelial cells, vascular smooth muscle cells, macrophages and T cells; (2) explore the complexity of metabolic cross-talk between these lesional cells; (3) highlight emerging technologies that promise to illuminate unknown aspects of metabolism in atherosclerosis; and (4) suggest strategies for targeting these underexplored metabolic alterations to mitigate atherosclerosis progression and stabilize rupture-prone atheromas with a potential new generation of cardiovascular therapeutics.

摘要

在过去几十年中,越来越多的证据表明,细胞代谢失调与动脉粥样硬化性心血管疾病的进展之间存在着复杂的关系。然而,人们对动脉粥样硬化性心血管疾病中细胞代谢失调的综合理解及其作为治疗靶点的潜在价值仍存在缺失。在这篇综述中,我们:(1)总结了近年来关于在病变细胞(包括内皮细胞、血管平滑肌细胞、巨噬细胞和 T 细胞)中,代谢失调在动脉粥样硬化进展过程中所起作用的最新进展;(2)探讨了这些病变细胞之间代谢交叉对话的复杂性;(3)强调了有望阐明动脉粥样硬化中代谢未知方面的新兴技术;(4)提出了针对这些尚未充分探索的代谢改变的策略,以减轻动脉粥样硬化的进展,并稳定易破裂的动脉粥样瘤,为心血管治疗带来新一代的潜在可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af54/11055680/ba5d2dc0f7de/nihms-1982057-f0001.jpg

相似文献

3
MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?微小 RNA-126、-145 和 -155:动脉粥样硬化治疗三联体?
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):449-54. doi: 10.1161/ATVBAHA.112.300279. Epub 2013 Jan 16.
9
Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis.PGC-1α在血管调节中的作用:对动脉粥样硬化的影响
Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1467-74. doi: 10.1161/ATVBAHA.116.307123. Epub 2016 Jun 16.

引用本文的文献

2
Anti-Atherogenic Mechanisms and Therapies.抗动脉粥样硬化机制与疗法
Curr Atheroscler Rep. 2025 Aug 20;27(1):83. doi: 10.1007/s11883-025-01324-9.
7
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis.血管平滑肌细胞:动脉粥样硬化的治疗靶点
Rev Cardiovasc Med. 2025 Jun 26;26(6):28240. doi: 10.31083/RCM28240. eCollection 2025 Jun.
10
Targeted drug delivery systems for atherosclerosis.用于动脉粥样硬化的靶向给药系统。
J Nanobiotechnology. 2025 Apr 23;23(1):306. doi: 10.1186/s12951-025-03384-0.

本文引用的文献

9
Identification of human exT cells as CD16CD56 cytotoxic CD4 T cells.鉴定人源细胞为 CD16CD56 细胞毒性 CD4 T 细胞。
Nat Immunol. 2023 Oct;24(10):1748-1761. doi: 10.1038/s41590-023-01589-9. Epub 2023 Aug 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验